Cargando…

Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease

Detalles Bibliográficos
Autores principales: Dufour, Inès, Devresse, Arnaud, Scohy, Anais, Briquet, Caroline, Georgery, Hélène, Delaey, Philippe, Greef, Julien De, Goffin, Eric, Labriola, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085722/
https://www.ncbi.nlm.nih.gov/pubmed/37037486
http://dx.doi.org/10.23876/j.krcp.22.194
_version_ 1785021996151603200
author Dufour, Inès
Devresse, Arnaud
Scohy, Anais
Briquet, Caroline
Georgery, Hélène
Delaey, Philippe
Greef, Julien De
Goffin, Eric
Labriola, Laura
author_facet Dufour, Inès
Devresse, Arnaud
Scohy, Anais
Briquet, Caroline
Georgery, Hélène
Delaey, Philippe
Greef, Julien De
Goffin, Eric
Labriola, Laura
author_sort Dufour, Inès
collection PubMed
description
format Online
Article
Text
id pubmed-10085722
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Society of Nephrology
record_format MEDLINE/PubMed
spelling pubmed-100857222023-04-11 Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease Dufour, Inès Devresse, Arnaud Scohy, Anais Briquet, Caroline Georgery, Hélène Delaey, Philippe Greef, Julien De Goffin, Eric Labriola, Laura Kidney Res Clin Pract Correspondence The Korean Society of Nephrology 2023-03 2023-03-31 /pmc/articles/PMC10085722/ /pubmed/37037486 http://dx.doi.org/10.23876/j.krcp.22.194 Text en Copyright © 2023 The Korean Society of Nephrology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial and No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) which permits unrestricted non-commercial use, distribution of the material without any modifications, and reproduction in any medium, provided the original works properly cited.
spellingShingle Correspondence
Dufour, Inès
Devresse, Arnaud
Scohy, Anais
Briquet, Caroline
Georgery, Hélène
Delaey, Philippe
Greef, Julien De
Goffin, Eric
Labriola, Laura
Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title_full Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title_fullStr Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title_full_unstemmed Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title_short Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
title_sort safety and efficiency of molnupiravir for covid-19 patients with advanced chronic kidney disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085722/
https://www.ncbi.nlm.nih.gov/pubmed/37037486
http://dx.doi.org/10.23876/j.krcp.22.194
work_keys_str_mv AT dufourines safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT devressearnaud safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT scohyanais safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT briquetcaroline safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT georgeryhelene safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT delaeyphilippe safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT greefjuliende safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT goffineric safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease
AT labriolalaura safetyandefficiencyofmolnupiravirforcovid19patientswithadvancedchronickidneydisease